SCHEMBL938644

SCHEMBL938644

COc1cc(C)c(S(=O)(=O)CNCc2nc3ccc(C(=O)O)cc3[nH]2)c(C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.47
APEX1 P27695 1/20 0.46
CHEK2 O96017 1/20 0.45
TDP1 Q9NUW8 2/20 0.45
HSP90AA1 P07900 1/20 0.45
ESR2 Q92731 1/20 0.45
ALDH1A1 P00352 2/20 0.44
MAPK1 P28482 1/20 0.44
PTPN1 P18031 1/20 0.44
TOP2A P11388 1/20 0.43
KLK1 P06870 1/20 0.43
KLK5 Q9Y337 1/20 0.43
DGAT1 O75907 1/20 0.42
CYP1A2 P05177 2/20 0.41
TSHR P16473 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
F10 P00742 1/20 0.41
CYP2E1 P05181 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C8 P10632 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1017833 0.91 APEX1 (0.49) NPSR1APEX1CHEK2TDP1HSP90AA1
SCHEMBL941268 0.82 NPSR1 (0.47) NPSR1APEX1CHEK2TDP1HSP90AA1
SCHEMBL938645 0.81 NPSR1 (0.50) NPSR1APEX1CHEK2TDP1HSP90AA1
SCHEMBL939861 0.80 LMNA (0.32) ALDH1A1PTPN1DGAT1SMN1; SMN2MAPT
SCHEMBL941263 0.80 KDM4C (0.39) NPSR1APEX1ALDH1A1MAPK1TSHR
SCHEMBL1017834 0.78 APEX1 (0.50) NPSR1APEX1CHEK2TDP1HSP90AA1
SCHEMBL11888786 0.76 CD38 (0.37) TSHRSMN1; SMN2TP53MAPK10
SCHEMBL939162 0.74 ALDH1A1 (0.46) CHEK2ALDH1A1MAPK1KLK1KLK5
SCHEMBL939376 0.73 PPARG (0.43) ALDH1A1SMN1; SMN2
SCHEMBL3167982 0.72 DGAT1 (0.68) CHEK2TDP1HSP90AA1ESR2DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8232288-B2 Substituted benzimidazoles, benzothiazoles and benzoxazoles GRUENENTHAL GMBH (DE) 2012-07-31 US disclosed
US-20110009382-A1 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles GRUENENTHAL GMBH (DE) 2011-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009382-A1 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles BDKRB1, BDKRB2, BRD1 NPSR1 228/4885APEX1 3873/4885CHEK2 978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.